Freya Mowat, PhD, is a veterinary ophthalmologist clinician–scientist. She completed veterinary studies at the University of Bristol in the U.K., and her PhD with Dr. Robin Ali and Dr. James Bainbridge at the University College London Institute of Ophthalmology, studying retinal oxygen signaling mechanisms. She completed veterinary ophthalmology specialty residency training and a postdoctoral research fellowship at Michigan State University under the mentorship of Dr. Simon Petersen-Jones, studying the retinal effects of gene augmentation therapy in the dog model of human Leber Congenital Amaurosis type 2.
Dr. Mowat is a board-certified veterinary ophthalmologist with both the American and European Colleges of Veterinary Ophthalmologists. She is currently an assistant professor at the University of Wisconsin–Madison with appointments in the School of Veterinary Medicine and School of Medicine and Public Health, where she teaches, has clinical duties in veterinary ophthalmology, and performs research. Her research laboratory focuses on retinal aging, toxicant exposures, and other risk factors for accelerated age-related sensory and cognitive decline.